Fishers, IN, United States of America

Ganapathy Gopalrathnam

USPTO Granted Patents = 3 

Average Co-Inventor Count = 24.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
3 patents (USPTO):

Title: Overview of Inventor Ganapathy Gopalrathnam

Introduction

Ganapathy Gopalrathnam is a notable inventor based in Fishers, IN, USA. With a total of three patents to his name, he has made significant contributions to the field of biotechnology, particularly in the development of anti-coronavirus technologies.

Latest Patents

Gopalrathnam's latest patents focus on anti-coronavirus antibodies and methods of use. These patents describe antibodies that specifically bind to the spike proteins of SARS-CoV and SARS-CoV-2, providing methods for treating or preventing conditions associated with SARS or COVID-19. Additionally, these inventions offer innovative approaches to detecting the virus strains, thereby aiding in public health responses.

Career Highlights

Throughout his career, Gopalrathnam has collaborated with reputable organizations. He has had impactful roles in organizations such as the Government of the United States, represented by the Secretary of the Department of Health and Human Services, and Abcellera Biologics Inc. His work is pivotal in advancing research in viral pathogens.

Collaborations

In his professional journey, Gopalrathnam has worked alongside talented individuals including Kathryn Westendorf and Stefanie Zentelis. Their teamwork has contributed to the success of his inventions and the further exploration of antibody applications.

Conclusion

Ganapathy Gopalrathnam's innovative spirit and commitment to advancements in biotechnology reflect the crucial role of inventors in addressing global health challenges. His contributions, particularly in combating coronavirus, underscore the importance of ongoing research and innovation in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…